{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T14:04:44Z","timestamp":1772114684667,"version":"3.50.1"},"reference-count":24,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Genetics"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1016\/j.cancergen.2012.11.001","type":"journal-article","created":{"date-parts":[[2012,12,10]],"date-time":"2012-12-10T23:03:07Z","timestamp":1355180587000},"page":"653-656","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Therapy-related pro-B cell acute lymphoblastic leukemia: report of two patients with MLL amplification"],"prefix":"10.1016","volume":"205","author":[{"given":"Frederick","family":"Racke","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carol","family":"Cole","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alison","family":"Walker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nyla A.","family":"Heerema","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cancergen.2012.11.001_bib1","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.3324\/haematol.11034","article-title":"Therapy-related leukemia and myelodysplasia: susceptibility and incidence","volume":"92","author":"Leone","year":"2007","journal-title":"Haematologica"},{"key":"10.1016\/j.cancergen.2012.11.001_bib2","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/PAP.0b013e31821698ef","article-title":"Therapy-associated lymphoid proliferations","volume":"18","author":"Bagg","year":"2011","journal-title":"Adv Anat Pathol"},{"key":"10.1016\/j.cancergen.2012.11.001_bib3","series-title":"WHO Classification of Tumours of Haematopoietic Lymphoid Tissues","first-page":"109","article-title":"Acute myeloid leukemia (AML) and related precursor neoplasms","author":"Vardiman","year":"2008"},{"key":"10.1016\/j.cancergen.2012.11.001_bib4","series-title":"WHO Classification of Tumours of Haematopoietic Lymphoid Tissues","first-page":"171","article-title":"Precursor lymphoid neoplasms","author":"Borowitz","year":"2008"},{"key":"10.1016\/j.cancergen.2012.11.001_bib5","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.molmed.2004.08.005","article-title":"MLL: a histone methyltransferase disrupted in leukemia","volume":"10","author":"Hess","year":"2004","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.cancergen.2012.11.001_bib6","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1182\/blood-2005-01-0204","article-title":"The MLL partial tandem duplication: evidence for recessive gain-of-function in acute myeloid leukemia identifies a novel patient subgroup for molecular-targeted therapy","volume":"106","author":"Whitman","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.cancergen.2012.11.001_bib7","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0165-4608(01)00602-1","article-title":"MLL amplification in myeloid malignancies: clinical, molecular, and cytogenetic findings","volume":"134","author":"Dolan","year":"2002","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.cancergen.2012.11.001_bib8","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/gcc.1115","article-title":"Duplication or amplification of chromosome band 11q23, including the unrearranged MLL gene, is a recurrent abnormality in therapy-related MDS and AML, and is closely related to mutation of the TP53 gene and to previous therapy with alkylating agents","volume":"31","author":"Andersen","year":"2001","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.cancergen.2012.11.001_bib9","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1046\/j.1365-2141.2001.03000.x","article-title":"Therapy-related acute lymphoblastic leukaemia with MLL rearrangements following DNA topoisomerase II inhibitors, an increasing problem: report on two new cases and review of the literature since 1992","volume":"114","author":"Andersen","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1016\/j.cancergen.2012.11.001_bib10","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1309\/AJCPYWC6AQC7BAVJ","article-title":"Therapy-related acute lymphoblastic leukemia without 11q23 abnormality: report of six cases and a literature review","volume":"133","author":"Chen","year":"2010","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.cancergen.2012.11.001_bib11","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1007\/BF02986622","article-title":"T-cell acute lymphoblastic leukemia as a secondary leukemia after a 3-year remission of\u00a0acute myelocytic leukemia","volume":"77","author":"Tsuboi","year":"2003","journal-title":"Int J Hematol"},{"key":"10.1016\/j.cancergen.2012.11.001_bib12","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1002\/gcc.10046","article-title":"11q23 balanced chromosome aberrations in treatment-related myelodysplastic syndromes and acute leukemia: report from an international workshop","volume":"33","author":"Bloomfield","year":"2002","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.cancergen.2012.11.001_bib13","doi-asserted-by":"crossref","first-page":"3962","DOI":"10.1002\/cncr.26735","article-title":"Therapy-related acute lymphoblastic leukemia is more frequent than previously recognized and has a poor prognosis","volume":"118","author":"Abdulwahab","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.cancergen.2012.11.001_bib14","doi-asserted-by":"crossref","first-page":"465","DOI":"10.3109\/10428190009113377","article-title":"Clinical and epidemiological features of acute lymphoblastic leukemia following a previous malignancy","volume":"39","author":"Pagano","year":"2000","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.cancergen.2012.11.001_bib15","doi-asserted-by":"crossref","first-page":"919","DOI":"10.3324\/haematol.2011.057752","article-title":"Precursor B-acute lymphoblastic leukemia occurring in patients with a history of prior malignancies: is it therapy-related?","volume":"97","author":"Tang","year":"2012","journal-title":"Haematologica"},{"key":"10.1016\/j.cancergen.2012.11.001_bib16","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1038\/sj.leu.2402918","article-title":"High frequency of pro-B acute lymphoblastic leukemia in adults with secondary leukemia with 11q23 abnormalities","volume":"17","author":"Ishizawa","year":"2003","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergen.2012.11.001_bib17","series-title":"ISCN 2009: An International System for Human Cytogenetic Nomenclature","year":"2009"},{"key":"10.1016\/j.cancergen.2012.11.001_bib18","doi-asserted-by":"crossref","first-page":"984","DOI":"10.3324\/haematol.2008.002436","article-title":"The molecular biology of mixed lineage leukemia","volume":"94","author":"Slany","year":"2009","journal-title":"Haematologica"},{"key":"10.1016\/j.cancergen.2012.11.001_bib19","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1038\/leu.2009.33","article-title":"New insights to the MLL recombinome of acute leukemias","volume":"23","author":"Meyer","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergen.2012.11.001_bib20","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1615\/CritRevEukaryotGeneExpr.v14.i4.10","article-title":"Mechanisms of transformation by MLL","volume":"14","author":"Hess","year":"2004","journal-title":"Crit Rev Eukaryot Gene Expr"},{"key":"10.1016\/j.cancergen.2012.11.001_bib21","first-page":"EIM03","article-title":"MLL intrachromosomal amplification in a pre-B acute lymphoblastic leukemia","volume":"88","author":"Espinet","year":"2003","journal-title":"Haematologica"},{"key":"10.1016\/j.cancergen.2012.11.001_bib22","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1038\/sj.leu.2401919","article-title":"MLL amplification in acute leukaemia: a United Kingdom Cancer Cytogenetics Group (UKCCG) study","volume":"14","author":"Cuthbert","year":"2000","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergen.2012.11.001_bib23","article-title":"Six cases of rare gene amplifications and multiple copy of fusion gene in childhood acute lymphoblastic leukemia","author":"Haltrich","year":"2012","journal-title":"Pathol Oncol Res"},{"key":"10.1016\/j.cancergen.2012.11.001_bib24","doi-asserted-by":"crossref","first-page":"e120","DOI":"10.1097\/MPH.0b013e3182273b57","article-title":"MLL duplication in a pediatric patient with B-cell lymphoblastic lymphoma","volume":"34","author":"Van Mater","year":"2012","journal-title":"J\u00a0Pediatr Hematol Oncol"}],"container-title":["Cancer Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210776212002700?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210776212002700?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:38:10Z","timestamp":1761896290000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210776212002700"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":24,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["S2210776212002700"],"URL":"https:\/\/doi.org\/10.1016\/j.cancergen.2012.11.001","relation":{},"ISSN":["2210-7762"],"issn-type":[{"value":"2210-7762","type":"print"}],"subject":[],"published":{"date-parts":[[2012,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapy-related pro-B cell acute lymphoblastic leukemia: report of two patients with MLL amplification","name":"articletitle","label":"Article Title"},{"value":"Cancer Genetics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cancergen.2012.11.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}